![Yi Li Xie](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Yi Li Xie
Directeur Financier/CFO chez
GRACELL BIOTECHNOLOGIES INC.
Profil
Yi Li Xie is the founder of Locust Walk Capital Management, which was founded in 2010.
He was the Managing Partner from 2010 to 2014.
Dr. Xie's current jobs include being a Director at PatientPoint, Inc. and the Chief Financial Officer at Gracell Biotechnologies, Inc. since 2020.
Dr. Xie's former jobs include being the Managing Director at Great Point Partners LLC from 2005 to 2008, the Head-Healthcare Sector at Scopia Capital Management LP from 2009 to 2010, and the President at Fosun Healthcare Holdings from 2015 to 2020.
Dr. Xie also served as an Independent Director at Alpha Healthcare Acquisition Corp., Luz Saúde SA, and Humanigen, Inc. from 2021 to 2023, 2019 to 2022, and 2021 to 2023, respectively.
Additionally, Dr. Xie was a Director at ViewRay, Inc. from 2019 to 2022, the Chief Scientific Officer at Boehringer Ingelheim GmbH, and the Managing Director at Great Point Partners Private Equity in 2008.
Dr. Xie's education includes an undergraduate degree from Tianjin University, a doctorate from City University of New York, and an MBA from The Wharton School of the University of Pennsylvania.
Postes actifs de Yi Li Xie
| Sociétés | Poste | Début |
|---|---|---|
| GRACELL BIOTECHNOLOGIES INC. | Directeur Financier/CFO | 24/07/2020 |
PatientPoint, Inc.
 PatientPoint, Inc. Packaged SoftwareTechnology Services Develops tools that provides health care services | Directeur/Membre du Conseil | - |
Anciens postes connus de Yi Li Xie
| Sociétés | Poste | Fin |
|---|---|---|
| HUMANIGEN, INC. | Directeur/Membre du Conseil | 19/07/2023 |
| VIEWRAY SYSTEMS, INC. | Directeur/Membre du Conseil | 08/03/2022 |
Fosun Healthcare Holdings
 Fosun Healthcare Holdings Hospital/Nursing ManagementHealth Services Operates a chain of hospitals | President | 01/01/2020 |
Kinglington Capital LLC | Corporate Officer/Principal | 01/03/2015 |
Locust Walk Capital Management
 Locust Walk Capital Management Investment ManagersFinance Locust Walk Capital Management employs a long/short investment strategy that focuses on the healthcare sector | Fondateur | 01/12/2014 |
Formation de Yi Li Xie
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
17
Relations au 1er degré
17
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 17 |
|---|---|
Nomura Investment Management Business Trust
 Nomura Investment Management Business Trust Investment ManagersFinance MIMBT maintains a flexible strategy designed to conform with various clients’ individual investment objectives. The firm manages separate client-focused equity, debt, and balanced portfolios. They invest in the public equity and debt markets of the US, non-US, and other emerging economies. MIMBT seeks growth-oriented value stocks of small-cap, mid-cap and large-cap companies. The firm selects countries by utilizing a top-down approach and selects stocks using fundamental analysis with a bottom-up approach. | Finance |
Boehringer Ingelheim GmbH
 Boehringer Ingelheim GmbH Pharmaceuticals: MajorHealth Technology Manufactures and wholesales animal health & pharmaceutical products | Health Technology |
Scopia Capital Management LP
 Scopia Capital Management LP Investment ManagersFinance Scopia employs a fundamentals-based, value-driven investment approach across two strategies: a long-short equity strategy managed with the discipline of market neutrality and a long-only equity strategy. The firm seeks to identify investments primarily in publicly-traded equities (on both US and non-US exchanges), including IPOs, and conversely to identify and sell short stocks that they believe will drop in value (or at least under-perform) regardless of the industry and the market’s overall direction. | Finance |
Great Point Partners LLC
 Great Point Partners LLC Investment ManagersFinance Great Point seeks to achieve positive excess returns by investing in publicly traded biotechnology, pharmaceutical and life science companies. The firm focuses on creating a balanced portfolio comprised primarily of companies that are undervalued by the public markets. Their hedge funds employ a bottom-up research-driven approach to investing in the securities of undervalued, publicly-traded healthcare companies. Great Point Partners targets fast-growing, technology- driven small-cap companies. In addition, the firm manages private equity funds that invest in private, primarily profitable, lower middle-market, growing healthcare companies. | Finance |
Humanigen, Inc.
 Humanigen, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that engages in development of cell and gene therapies for treatment of cancers and infectious diseases | Health Technology |
ViewRay, Inc.
 ViewRay, Inc. Medical SpecialtiesHealth Technology Designs, manufactures and markets the meridian radiation therapy system | Health Technology |
Luz Saúde SA
 Luz Saúde SA Hospital/Nursing ManagementHealth Services Operates general hospitals and provides clinical services | Health Services |
Tianjin University
 Tianjin University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
City University of New York
 City University of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Great Point Partners Private Equity
 Great Point Partners Private Equity Investment ManagersFinance Great Point Partners invests in companies located in the United States, Canada and Western Europe with an EBITDA ranging from USD 2 - 12 million and revenue ranging from USD 10 - 100 million. The firm targets companies operating in the fields of healthcare sectors and industries. It provides financing for buyout and growth capital requirements with an investment size ranging from USD 10 - 100 million. The firm acquires minority and majority interests and also acts as lead investor. | Finance |
Locust Walk Capital Management
Locust Walk Capital Management Investment ManagersFinance Locust Walk Capital Management employs a long/short investment strategy that focuses on the healthcare sector | Finance |
PatientPoint, Inc.
PatientPoint, Inc. Packaged SoftwareTechnology Services Develops tools that provides health care services | Technology Services |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fosun Healthcare Holdings
Fosun Healthcare Holdings Hospital/Nursing ManagementHealth Services Operates a chain of hospitals | Health Services |
Gracell Biotechnologies, Inc.
 Gracell Biotechnologies, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops cell and gene therapy for the treatment of cancer and autoimmune diseases | Health Technology |
Alpha Healthcare Acquisition Corp.
 Alpha Healthcare Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Kinglington Capital LLC |
